- Issuer ticker
-
DNLI
- Reported as of
-
12 Aug 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
14 Aug 2026, 16:48:18 UTC
Filing notes and source
Key filing fact
Ryan J. Watts filed Form 4 for Denali Therapeutics Inc. (DNLI) on 14 Aug 2026.
Key facts
- This page summarizes Ryan J. Watts's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2026, 16:48.
Change
- Previous filing in this sequence was filed on 08 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001724310
Primary reporting owner
Watts Ryan J.
- Relationship
-
President and CEO, Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNLI
transaction
Common Stock
Gift
- Transaction value
- Shares
- -32,220
- Change %
- -1.5%
- Price
-
$0.000000*
- Shares after
- 2,120,384
- Date
- 12 Aug 2026
- Ownership
- See footnote
- Footnotes
- F1, F2
DNLI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 296,833
- Date
- 12 Aug 2026
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes